THE INFLUENCE OF TUMOR IMMUNE MICROENVIRONMENT AND TUMOR IMMUNITY ON THE PATHOGENESIS, TREATMENT AND PROGNOSIS OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD)

MLA

Kentaro Fukushima, et al. “The Influence of Tumor Immune Microenvironment and Tumor Immunity on the Pathogenesis, Treatment and Prognosis of Post-Transplant Lymphoproliferative Disorders (Ptld).” Hematological Oncology, vol. 37, June 2019, pp. 200–01. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4221a22f1ab05178a96ce2ad9f932ad9&authtype=sso&custid=ns315887.

APA

Kentaro Fukushima, Kouichi Ohshima, Hiroaki Miyoshi, Masao Seto, Kenji Oritani, Jun Toda, Yuzuru Kanakura, Tetsuo Maeda, Takafumi Yokota, Masao Mizuki, Hirohiko Shibayama, Hideaki Saito, Shinsuke Kusakabe, Michiko Ichii, & Jiro Fujita. (2019). The Influence of Tumor Immune Microenvironment and Tumor Immunity on the Pathogenesis, Treatment and Prognosis of Post-Transplant Lymphoproliferative Disorders (Ptld). Hematological Oncology, 37, 200–201.

Chicago

Kentaro Fukushima, Kouichi Ohshima, Hiroaki Miyoshi, Masao Seto, Kenji Oritani, Jun Toda, Yuzuru Kanakura, et al. 2019. “The Influence of Tumor Immune Microenvironment and Tumor Immunity on the Pathogenesis, Treatment and Prognosis of Post-Transplant Lymphoproliferative Disorders (Ptld).” Hematological Oncology 37 (June): 200–201. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4221a22f1ab05178a96ce2ad9f932ad9&authtype=sso&custid=ns315887.